U.S. flag

An official website of the United States government, Department of Justice.

Wisconsin 2019 Comprehensive Opioid Abuse Site-based Program

Award Information

Award #
2019-AR-BX-K051
Funding Category
Competitive Discretionary
Location
Congressional District
Status
Past Project Period End Date
Funding First Awarded
2019
Total funding (to date)
$5,000,000

Description of original award (Fiscal Year 2019, $5,000,000)

The Comprehensive Opioid Abuse Site-based Program (COAP) was developed as part of the Comprehensive Addiction and Recovery Act (CARA) legislation. COAP’s purpose is to provide financial and technical assistance to states, units of local government, and Indian tribal governments to plan, develop, and implement comprehensive efforts to identify, respond to, treat, and support those impacted by the opioid epidemic. The Harold Rogers Prescription Drug Monitoring Program (PDMP) has been incorporated into the FY 2019 COAP solicitation. The purpose of the Harold Rogers PDMP is to improve collaboration and strategic decision making among regulatory and law enforcement agencies and public health entities to address prescription drug and opioid abuse, save lives, and reduce crime.

COAP aims to reduce opioid abuse and the number of overdose fatalities, as well as to mitigate the impacts on crime victims by supporting comprehensive, collaborative initiatives. The program also supports the implementation, enhancement, and proactive use of PDMPs to support clinical decision making and prevent the abuse and diversion of controlled substances. Grantees are prohibited from using federal funds to support activities that violate the Controlled Substances Act.

The objective of Category 2 is to support states in their efforts to implement, enhance, or evaluate effective opioid-related efforts within the criminal justice system.

The Wisconsin Department of Justice (DOJ) will support the implementation of local Law Enforcement Assisted Diversion (LEAD) programs and Medication-Assisted Treatment (MAT) programs in jails. Five pre-booking diversion sites using the LEAD model will be selected to provide diversion to treatment at pre-arrest or post-arrest stage. Nine jail-based sites will be selected to provide nonnarcotic, non-addictive injectable MAT to an inmate in the days immediately preceding re-entry to the community. The MAT program will include community-based care coordination for inmates exiting the county or tribal jail and rely on evidence-based, trauma-informed practices for substance use disorder treatment.This project will engage the Wisconsin Department of Justice's Bureau of Justice Information and Analysis as the research partner for this project.

CA/NCF

Date Created: September 29, 2019